These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 5646469)
1. Serological responses of mice during active enhancement of tumour allografts. Mildenhall P; Nelson DS Br J Exp Pathol; 1968 Apr; 49(2):170-8. PubMed ID: 5646469 [No Abstract] [Full Text] [Related]
2. Transplantation immunity: localization in mouse serum of antibodies responsible for haemagglutination, cytotoxicity and enhancement. Voisin GA; Kinsky RG; Jansen FK Nature; 1966 Apr; 210(5032):138-9. PubMed ID: 4164146 [No Abstract] [Full Text] [Related]
3. Biological properties of antibody classes in transplantation immune sera. Voisin GA; Kinsky R; Jansen F; Bernard C Transplantation; 1969 Nov; 8(5):618-32. PubMed ID: 4994819 [No Abstract] [Full Text] [Related]
4. Complete in vivo destruction of allografted sarcoma I cells by circulating antibodies. Kinsky R; Chouroulinkov I; Voisin GA Transplantation; 1970 Nov; 10(5):450-1. PubMed ID: 5490529 [No Abstract] [Full Text] [Related]
5. Effects of in vivo adsorption of immune serum to donor spleen cells on allograft rejection in X-irradiated mice. Cruse JM; Dulaney AD Z Immunitatsforsch Allerg Klin Immunol; 1966 May; 130(4):329-36. PubMed ID: 4231165 [No Abstract] [Full Text] [Related]
6. IMMUNOLOGICAL HOMOGRAFT ENHANCEMENT. INTERACTIONS OF ANTISERUM AND SKIN AND TUMOR HOMOGRAFTS. BERNE BH Proc Soc Exp Biol Med; 1965 Jan; 118():228-33. PubMed ID: 14254554 [No Abstract] [Full Text] [Related]
7. Demonstration of a tumour and transplantation antigen in hamster tumours induced by an avian adenovirus (CELO). Schild GC; Oxford JS; Potter CW Arch Gesamte Virusforsch; 1970; 29(1):25-31. PubMed ID: 4916367 [No Abstract] [Full Text] [Related]
8. The development and specific suppression of concomitant immunity in two syngeneic tumour-host systems. Chandradasa KD Int J Cancer; 1973 May; 11(3):648-62. PubMed ID: 4598551 [No Abstract] [Full Text] [Related]
10. Immunogenic properties of purified antigen preparations from a mouse sarcoma. Graff RJ; Kandutsch AA Transplantation; 1966 Jul; 4(4):465-73. PubMed ID: 5338634 [No Abstract] [Full Text] [Related]
11. [Methodical problems in demonstration of heterologous and homologous circulating antibodies of the kidney]. Tacke A; Schneeweiss B; Erdmann T Acta Biol Med Ger; 1971; 26(1):151-63. PubMed ID: 5577785 [No Abstract] [Full Text] [Related]
12. Inhibitory effect of immune serum on carcinogenesis in mice neonatally infected with murine sarcoma virus (Harvey). BubenÃk J; Turano A Folia Biol (Praha); 1968; 14(6):433-9. PubMed ID: 4303534 [No Abstract] [Full Text] [Related]
13. Tumor-specific active enhancement of a murine sarcoma. Bloom ET; Hildemann WH Tissue Antigens; 1971; 1(1):5-13. PubMed ID: 5154368 [No Abstract] [Full Text] [Related]
14. [Mechanisms common to autoimmune injuries and homograft rejection]. Voisin GA Pathol Biol (Paris); 1969 May; 17(9):509-20. PubMed ID: 4184677 [No Abstract] [Full Text] [Related]
15. Immune status of mice tolerant of living cells. II. Continuous presence and nature of facilitation-enhancing antibodies in tolerant animals. Voisin GA; Kinsky RG; Duc HT J Exp Med; 1972 May; 135(5):1185-203. PubMed ID: 4623319 [TBL] [Abstract][Full Text] [Related]
16. Effect of rat tumor allografts on the blood level of passively transferred alloantibodies. Buchsbaum DJ Proc Soc Exp Biol Med; 1972 Apr; 139(4):1197-201. PubMed ID: 4112429 [No Abstract] [Full Text] [Related]